Pfizer forecasts 2025 revenue of up to $64 billion and adjusted earnings growth, navigating cost challenges amid Medicare changes and advancing promising drug pipeline assets,...
Pfizer, the pharmaceutical giant, revealed a significant quarterly loss for the third quarter, largely attributed to charges associated with the struggles of its Covid antiviral...
A peer-reviewed study released on Monday reveals that an oral weight loss drug developed by Pfizer demonstrates similar efficacy and faster results compared to Novo...
In a positive move, the Centers for Disease Control and Prevention (CDC) recently endorsed updated COVID-19. This opens the door to a fall vaccination campaign that...